Zeng Rong, Wang Zuoguang, Cheng Wenli, Yang Kun
Centre of Hypertension, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Front Cardiovasc Med. 2022 Mar 7;9:850223. doi: 10.3389/fcvm.2022.850223. eCollection 2022.
Previous studies found visit-to-visit heart rate variability (VVHRV) may be positively associated with risks of several cardiovascular events, but whether VVHRV affected the benefit of intensive blood pressure control remained unknown. In this study, we assessed the risk of the composite cardiovascular outcomes associated with VVHRV among the older patients with hypertension and evaluated whether the benefit of intensive blood pressure control in the prevention of the composite cardiovascular outcomes was consistent in the context of elevated VVHRV.
This was a analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). We explored the relationship between VVHRV and the composite cardiovascular outcomes by multivariate Cox proportional hazard regressions. The primary endpoint was the composite cardiovascular outcomes, same as SPRINT, defined as a composite of myocardial infarction, stroke, heart failure, and/or death from cardiovascular causes. We used multiple adjustment models for all regressions.
Nine thousand two hundred and fourty-seven patients from the SPRINT were included in our analysis. We found a positive association between VVHRV and the risk of composite cardiovascular outcomes among the elderly with hypertension. Per 1 CV increment in HRCV, the hazard ratio of the risk of composite cardiovascular outcomes was 1.04 (95CI: 1.03, 1.05) in the fully adjusted Model. The benefit of intensive blood pressure control in managing cardiovascular events was consistent in different VVHRV subgroups. There was no significant interaction in other confounders.
We found the VVHRV was associated with the composite cardiovascular outcomes among the elderly with hypertension, intensive blood pressure control did not change the above association, and the benefits of intensive blood pressure management were consistent across different VVHRV groups.
既往研究发现,逐次就诊心率变异性(VVHRV)可能与多种心血管事件的风险呈正相关,但VVHRV是否会影响强化血压控制的获益尚不清楚。在本研究中,我们评估了老年高血压患者中与VVHRV相关的复合心血管结局的风险,并评估了在VVHRV升高的情况下,强化血压控制在预防复合心血管结局方面的获益是否一致。
这是一项对收缩压干预试验(SPRINT)的分析。我们通过多变量Cox比例风险回归探讨了VVHRV与复合心血管结局之间的关系。主要终点与SPRINT相同,为复合心血管结局,定义为心肌梗死、中风、心力衰竭和/或心血管原因导致的死亡的复合。所有回归分析我们都使用了多重调整模型。
SPRINT研究中的9247例患者纳入了我们的分析。我们发现高血压老年患者中VVHRV与复合心血管结局风险之间呈正相关。在完全调整模型中,每增加1个CV的HRCV,复合心血管结局风险的风险比为1.04(95%CI:1.03,1.05)。强化血压控制在管理心血管事件方面的获益在不同的VVHRV亚组中是一致的。在其他混杂因素方面没有显著的交互作用。
我们发现高血压老年患者中VVHRV与复合心血管结局相关,强化血压控制并未改变上述关联,且强化血压管理的获益在不同VVHRV组中是一致的。